Advocate Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ATO
Advocate Group's MRK Position: Q2 2026 in Review
Advocate Group reduced its Merck (MRK) stake by 7% in Q2 2026, selling an estimated $793K and leaving 90,572 shares worth $11.6M. The position accounts for 1.75% of the portfolio, ranked #12.
Advocate Group first reported a position in MRK in Q2 2022 and has held it in 17 quarters since. The position peaked at $11.7M in Q1 2026. 1,549 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Advocate Group held 90,572 shares of Merck worth $11.6M as of Q2 2026.
- Advocate Group sold 6,778 Merck shares in Q2 2026, an estimated $793K.
- Merck made up 1.75% of Advocate Group's portfolio in Q2 2026, its #12 holding.
- Advocate Group first reported a position in Merck in Q2 2022 and has held it in 17 quarters since.
- Advocate Group's Merck position peaked at $11.7M in Q1 2026.
- 1,549 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Advocate Group's 13F filing for Q2 2026, filed 17 Jul 2026.